Xcout Intel
NanoBio Corp competitors & alternatives
The 12 closest competitors and alternatives to NanoBio Corp among biotechnology companies — ranked by similarity to what NanoBio Corp actually does, not by market-cap band.
Subscribe to see NanoBio Corp’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About NanoBio Corp
NanoBio Corp. is a biopharmaceutical company based in Ann Arbor, Michigan, focused on developing dermatological products and anti-infective treatments.
NanoBio Corp at a glance
NanoBio Corp is a biotechnology company headquartered in United States. It has raised at least $16.7M across the 5 funding rounds on record, 4 of them with a disclosed amount. Its most recent funding round raised $10M in May 2018. Xcout tracks 1 named person at NanoBio Corp, including Needa Brown (Principal Investigator).
NanoBio Corp leadership
- Needa BrownPrincipal Investigator
NanoBio Corp funding rounds
At least $16.7M raised across the 5 rounds on record (4 with a disclosed amount). Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| — | $10M | 1 named | |
| SEC Form D filing | $775,000 | — | |
| SEC Form D filing | $1.8M | — | |
| Series B | $4.1M | — | |
| Seed | Undisclosed | 1 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 NanoBio Corp competitors
Ranked by semantic similarity — how close each company is to NanoBio Corp by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotechnology company
BlueWillow Biologics, Inc. is a privately held clinical-stage biopharmaceutical company located in Ann Arbor, Michigan. The company specializes in the development of proprietary intranasal vaccines and immune-modulating technologies.
Similar biotechnology company
MDI Therapeutics, Inc. is a pharmaceutical company headquartered in Novi, Michigan. The company specializes in researching and developing novel therapeutics for the treatment of fibrosis and related fibrotic diseases.
Biotech
NanoViricides, Inc. operates as a nano-biopharmaceutical entity, specializing in the research, development, and market introduction of pharmaceutical solutions to combat viral infections. The company's robust product pipeline includes a Human Coronavirus Program, specifically engineered to tackle both COVID-19 and various seasonal coronaviruses. For herpes-related conditions, it offers HerpeCide in multiple forms: dermal topical and eye drops to treat ailments such as shingles, postherpetic neuralgia (PHN), chickenpox, recurrent herpes labialis, genital herpes, and ocular herpes keratitis. An intraocular injectable version of HerpeCide is also under development for viral acute retinal necrosis. Another significant therapeutic candidate is FluCide, a broad-spectrum anti-influenza nanoviricide, designed for both hospitalized patients via injection and outpatients through an oral formulation. NanoViricides also develops specialized nanoviricide eye drops for viral diseases affecting the external eye, DengueCide for various strains of Dengue viruses, and HIVCide, an anti-HIV nanoviricide specifically engineered to resist viral escape. Furthermore, the company is actively advancing additional nanoviricide drug projects targeting a diverse range of viruses and indications, alongside expanding its HerpeCide program to encompass a broader spectrum of herpes viruses and associated conditions. NanoViricides, Inc. was established in 2005 and maintains its corporate headquarters in Shelton, Connecticut.
Similar biotechnology company
Micron Biomedical, Inc. is a clinical-stage biopharmaceutical and life science company committed to expanding global access to therapeutics and vaccines formulated into proprietary array-based delivery technologies.
Similar biotechnology company
AMR Bio is a clinical-stage biotechnology company headquartered in London, United Kingdom, focused on infection prevention and antimicrobial resistance. The company is dedicated to developing novel anti-infectives, including its Phase 3-ready, first-in-class topical antimicrobial candidate XF-73.
Similar biotechnology company
Aeolus Pharmaceuticals, Inc. is a biopharmaceutical company located in Mission Viejo, California, focused on developing a platform of compounds for biodefense and fibrosis applications.
Similar biotechnology company
Arcutis Biotherapeutics is a biotechnology company focused on medical dermatology innovation. The company is publicly traded and dedicated to delivering meaningful treatments in the dermatology field.
Similar biotechnology company
IntraBio Inc. is a US pharmaceutical corporation with its principal operations located in Oxford, United Kingdom, and corporate offices in Austin, Texas.
Life Sciences
Tetra Discovery Partners is a biopharmaceutical company headquartered in Grand Rapids, Michigan, with a business office in Cambridge, Massachusetts.
Similar biotechnology company
Antiva Biosciences, Inc. is a clinical-stage biopharmaceutical company headquartered in South San Francisco, California. The firm focuses on biotechnology research and developing treatments for viral infections and precancerous conditions.
Similar biotechnology company
ONL Therapeutics, Inc. is a clinical-stage biopharmaceutical company located in Michigan, United States, focused on the development of novel therapies for retinal diseases.
Similar biotechnology company
C3J Therapeutics, Inc. is a clinical-stage biotechnology company based in Los Angeles, California, focused on improving human health through the development of targeted antimicrobials.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of NanoBio Corp and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for NanoBio Corpand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →